Implementing an infection control and prevention program decreases the incidence of healthcare-associated infections and antibiotic resistance in a Russian neuro-ICU

被引:27
作者
Ershova, Ksenia [1 ]
Savin, Ivan [2 ]
Kurdyumova, Nataliya [2 ]
Wong, Darren [3 ]
Danilov, Gleb [4 ]
Shifrin, Michael [5 ]
Alexandrova, Irina [6 ]
Sokolova, Ekaterina [2 ]
Fursova, Nadezhda [7 ]
Zelman, Vladimir [1 ,8 ]
Ershova, Olga [9 ]
机构
[1] Skolkovo Inst Sci & Technol, Ctr Data Intens Biotechnol & Biomed, Moscow, Russia
[2] Burdenko Natl Med Res Ctr Neurosurg, Dept Intens Care, Moscow, Russia
[3] Univ Southern Calif, Keck Sch Med, Div Infect Dis, Los Angeles, CA USA
[4] Burdenko Natl Med Res Ctr Neurosurg, Lab Biomed Informat, Moscow, Russia
[5] Burdenko Natl Med Res Ctr Neurosurg, IT Dept, Moscow, Russia
[6] Burdenko Natl Med Res Ctr Neurosurg, Dept Microbiol, Moscow, Russia
[7] SRCAMB, Fed Budget Inst Sci, Moscow, Russia
[8] Univ Southern Calif, Keck Sch Med, Dept Anesthesiol, Los Angeles, CA USA
[9] Burdenko Natl Med Res Ctr Neurosurg, Dept Epidemiol & Infect Control, Moscow, Russia
来源
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL | 2018年 / 7卷
关键词
Cross infection; Intensive care unit Infection control; Drug resistance; Survival analysis; NOSOCOMIAL INFECTIONS; ACQUIRED INFECTIONS; SURVEILLANCE; MORTALITY;
D O I
10.1186/s13756-018-0383-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The impact of infection prevention and control (IPC) programs in limited resource countries such as Russia are largely unknown due to a lack of reliable data. The aim of this study is to evaluate the effect of an IPC program with respect to healthcare associated infection (HAI) prevention and to define the incidence of HAIs in a Russian ICU. Methods: A pioneering IPC program was implemented in a neuro-ICU at Burdenko Neurosurgery Institute in 2010 and included hand hygiene, surveillance, contact precautions, patient isolation, and environmental cleaning measures. This prospective observational cohort study lasted from 2011 to 2016, included high-risk ICU patients, and evaluated the dynamics of incidence, etiological spectrum, and resistance profile of four types of HAIs, including subgroup analysis of device-associated infections. Survival analysis compared patients with and without HAIs. Results: We included 2038 high-risk patients. By 2016, HAI cumulative incidence decreased significantly for respiratory HAIs (36.1% vs. 24.5%, p-value = 0.0003), urinary-tract HAIs (29.1% vs. 21.3%, p-value = 0.0006), and healthcare-associated ventriculitis and meningitis (HAVM) (16% vs. 7.8%, p-value = 0.004). The incidence rate of EVD-related HAVM dropped from 22.2 to 13.5 cases per 1000 EVD-days. The proportion of invasive isolates of Klebsiella pneumoniae and Acinetobacter baumannii resistant to carbapenems decreased 1.7 and 2 fold, respectively. HAVM significantly impaired survival and independently increasing the probability of death by 1.43. Conclusions: The implementation of an evidence-based IPC program in a middle-income country (Russia) was highly effective in HAI prevention with meaningful reductions in antibiotic resistance.
引用
收藏
页数:11
相关论文
共 27 条
[1]  
Agarwal A, 2009, Med J Armed Forces India, V65, P264, DOI 10.1016/S0377-1237(09)80020-8
[2]   Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis [J].
Allegranzi, Benedetta ;
Nejad, Sepideh Bagheri ;
Combescure, Christophe ;
Graafmans, Wilco ;
Attar, Homo ;
Donaldson, Liam ;
Pittet, Didier .
LANCET, 2011, 377 (9761) :228-241
[3]  
[Anonymous], 2017, STAT REP STAT SAN EP, P128
[4]  
[Anonymous], 2001, SciPy: Open source scientific tools for Python
[5]  
[Anonymous], 2016, HLTH CAR RUSS 2015, p[18, 97]
[6]  
[Anonymous], 2007, GUIDELINE ISOLATION
[7]  
[Anonymous], 2017, Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities
[8]  
[Anonymous], 2010, P 9 PYTH SCI C ED S
[9]  
Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P149
[10]  
Clinical and Laboratory Standard Institute, 2016, M100 CLIN LAB STAND